Campath ®

Generic Name: Alemtuzumab

Drug Type:

Campath is a monoclonal antibody. (For more detail see "How Campath Works" section below).

What Campath Is Used For:

Note: If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful.

How Campath Is Given:

Side Effects of Campath:

Important things to remember about the side effects of Campath:

Infusion-related side effects (symptoms which may occur during the actual treatment) include:

The following are common (occurring in greater than 30%) side effects for patients taking Campath:

These are less common side effects (occurring in 10-29% ) for patients receiving Campath:

Not all side effects are listed above, some that are rare (occurring in less than 10% of patients) are not listed here. However, you should always inform your health care provider if you experience any unusual symptoms.

When To Contact Your Doctor or Health Care Provider:

Contact your health care provider immediately, day or night, if you should experience the following:

The following symptoms require medical attention, but are not an emergency. Contact your health care provider within 24 hours after noticing any of the following:

Campath Precautions:

Campath Self Care Tips:

Monitoring and Testing While Taking Campath:

You will be checked regularly by your doctor while you are taking Campath, to monitor side effects and check your response to therapy. Periodic blood work to monitor your complete blood count (CBC) as well as the function of other organs (such as your kidneys and liver) will also be ordered by your doctor.

How Campath Works:

Monoclonal antibodies are a relatively new type of "targeted" cancer therapy.

Antibodies are an integral part of the body's immune system. Normally, the body creates antibodies in response to an antigen (such as a protein in a germ) that has entered the body. The antibodies attach to the antigen in order to mark it for destruction by the immune system.

To make anti-cancer monoclonal antibodies in the laboratory, scientists analyze specific antigens on the surface of cancer cells (the targets). Then, using animal and human proteins, they create a specific antibody that will attach to the target antigen on the cancer cells. When given to the patient, these monoclonal antibodies will attach to matching antigens like a key fits a lock.

Since monoclonal antibodies target only specific cells, they may cause less toxicity to healthy cells. Monoclonal antibody therapy are usually given only for cancers in which antigens (and the respective antibodies) have been identified already.

Campath is a monoclonal antibody that targets an antigen known as CD52, a common antigen found on B and T cells (part of the body's immune system). When the Campath antibody attaches to the CD52 antigen, the body's immune system is activated to destroy these targeted cells in the blood and bone marrow. Since the CD52 antigen is also present on healthy B and T cells, however, treatment will temporarily weaken your immune system and care must be taken to protect you from infection during treatment.

Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.